|
AU2015243849B2
(en)
|
2014-04-10 |
2020-12-17 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Transgene genetic tags and methods of use
|
|
KR102211120B1
(ko)
|
2014-05-15 |
2021-02-03 |
내셔널 유니버시티 오브 싱가포르 |
변형된 천연 살해 세포 및 그의 용도
|
|
IL301458A
(en)
|
2014-12-24 |
2023-05-01 |
Autolus Ltd |
A cell that simultaneously expresses a chimeric antigen receptor (CAR) of 19CD and 22CD
|
|
GB201503742D0
(en)
*
|
2015-03-05 |
2015-04-22 |
Ucl Business Plc |
Chimeric antigen receptor
|
|
JP7162530B2
(ja)
|
2015-08-07 |
2022-10-28 |
シアトル チルドレンズ ホスピタル （ディービーエイ シアトル チルドレンズ リサーチ インスティテュート） |
固形腫瘍を標的とする二重特異性ｃａｒ ｔ細胞
|
|
US9681109B2
(en)
*
|
2015-08-20 |
2017-06-13 |
Qualcomm Incorporated |
Systems and methods for configurable demodulation
|
|
EP3443001B1
(en)
|
2016-04-11 |
2025-04-30 |
Obsidian Therapeutics, Inc. |
REGULATED BIOCIRCUIT SYSTEMS
|
|
CN108395482B
(zh)
|
2017-02-08 |
2021-02-05 |
西比曼生物科技（香港）有限公司 |
一种靶向cd20抗原嵌合抗原受体的构建及其工程化t细胞的活性鉴定
|
|
WO2018182511A1
(en)
|
2017-03-27 |
2018-10-04 |
National University Of Singapore |
Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
|
|
IL269553B2
(en)
|
2017-03-27 |
2025-10-01 |
Nat Univ Singapore |
Truncated NKG2D chimeric receptors and their uses in immunotherapy with natural killer cells
|
|
CN107098981B
(zh)
*
|
2017-06-29 |
2020-05-01 |
青岛麦迪赛斯医疗技术有限公司 |
一种靶向cd19的嵌合抗原受体修饰的t淋巴细胞
|
|
US20210130775A1
(en)
*
|
2017-08-02 |
2021-05-06 |
Autolus Limited |
Cells expressing a chimeric antigen receptor or engineered tcr and comprising a nucleotide sequence which is selectively expressed
|
|
KR102136063B1
(ko)
*
|
2017-12-06 |
2020-07-22 |
앱클론(주) |
악성 b 세포를 특이적으로 인지하는 항체 또는 그의 항원 결합 단편, 이를 포함하는 키메라 항체 수용체 및 이의 용도
|
|
CN107903326B
(zh)
*
|
2018-01-02 |
2020-06-30 |
广东省人民医院(广东省医学科学院) |
包含C3aR胞内结构域的嵌合抗原受体、慢病毒载体、表达细胞及药物
|
|
CN108047332B
(zh)
*
|
2018-01-15 |
2021-08-24 |
阿思科力(苏州)生物科技有限公司 |
以cd19为靶点的特异性抗体、car-nk细胞及其制备和应用
|
|
CN111801348A
(zh)
|
2018-02-09 |
2020-10-20 |
新加坡国立大学 |
活化性嵌合受体及其在自然杀伤细胞免疫疗法中的用途
|
|
TW201934575A
(zh)
*
|
2018-02-11 |
2019-09-01 |
大陸商江蘇恆瑞醫藥股份有限公司 |
一種分離的嵌合抗原受體以及包含其的修飾ｔ細胞及用途
|
|
SG11202008976YA
(en)
|
2018-04-02 |
2020-10-29 |
Nat Univ Singapore |
Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
|
|
CN116836297A
(zh)
*
|
2018-04-12 |
2023-10-03 |
上海赛比曼生物科技有限公司 |
靶向bcma的嵌合抗原受体及其制法和应用
|
|
GB201807870D0
(en)
|
2018-05-15 |
2018-06-27 |
Autolus Ltd |
A CD79-specific chimeric antigen receptor
|
|
AU2019269118B2
(en)
|
2018-05-15 |
2025-02-27 |
Autolus Limited |
Chimeric antigen receptor
|
|
CN108794642A
(zh)
*
|
2018-07-05 |
2018-11-13 |
宁波安诺柏德生物医药科技有限公司 |
一种嵌合抗原细胞受体及其应用
|
|
CN110819678A
(zh)
*
|
2018-08-07 |
2020-02-21 |
上海恒润达生生物科技有限公司 |
一种评估cart细胞有效性的方法
|
|
CN110850068B
(zh)
*
|
2018-08-21 |
2023-08-15 |
上海恒润达生生物科技股份有限公司 |
一种嵌合抗原受体亲和力检测方法
|
|
EP3844186A4
(en)
|
2018-08-29 |
2022-08-17 |
National University of Singapore |
METHOD OF SPECIFIC STIMULATION OF SURVIVAL AND EXPANSION OF GENETICALLY MODIFIED IMMUNE CELLS
|
|
FI3856775T3
(fi)
|
2018-09-27 |
2024-12-04 |
Autolus Ltd |
Kimeerinen antigeenireseptori
|
|
GB201816522D0
(en)
|
2018-10-10 |
2018-11-28 |
Autolus Ltd |
Methods and reagents for analysing nucleic acids from single cells
|
|
WO2020092839A1
(en)
|
2018-10-31 |
2020-05-07 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
EP3873540A4
(en)
|
2018-10-31 |
2022-07-27 |
Mayo Foundation for Medical Education and Research |
METHODS AND MATERIALS FOR THE TREATMENT OF CANCER
|
|
CA3116412A1
(en)
|
2018-10-31 |
2020-05-07 |
Humanigen, Inc. |
Materials and methods for treating cancer
|
|
WO2020088631A1
(en)
|
2018-11-01 |
2020-05-07 |
Gracell Biotechnologies (Shanghai) Co., Ltd. |
Compositions and methods for t cell engineering
|
|
CN109468282B
(zh)
*
|
2018-11-22 |
2019-06-18 |
青岛协和华美医学诊断技术有限公司 |
一种靶向cd19的嵌合抗原受体t细胞的制备方法及应用
|
|
CA3120563A1
(en)
|
2018-11-26 |
2020-06-04 |
Nkarta, Inc. |
Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
|
|
CN109734813B
(zh)
*
|
2019-01-28 |
2022-06-17 |
广东昭泰体内生物医药科技有限公司 |
一种嵌合抗原受体及其应用
|
|
US12241061B2
(en)
*
|
2019-02-04 |
2025-03-04 |
National University Corporation Ehime University |
CAR library and scFv manufacturing method
|
|
US12419913B2
(en)
|
2019-02-08 |
2025-09-23 |
Dna Twopointo, Inc. |
Modification of CAR-T cells
|
|
JP7588080B2
(ja)
|
2019-02-13 |
2024-11-21 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド |
抗末梢リンパ節アドレッシン抗体およびその使用
|
|
WO2020180882A1
(en)
|
2019-03-05 |
2020-09-10 |
Nkarta, Inc. |
Cd19-directed chimeric antigen receptors and uses thereof in immunotherapy
|
|
CN113543792A
(zh)
*
|
2019-03-08 |
2021-10-22 |
奥托路斯有限公司 |
包含工程化嵌合抗原受体和car调节剂的组合物和方法
|
|
GB201903237D0
(en)
|
2019-03-08 |
2019-04-24 |
Autolus Ltd |
Method
|
|
WO2020247392A1
(en)
*
|
2019-06-04 |
2020-12-10 |
Nkarta, Inc. |
Combinations of engineered natural killer cells and engineered t cells for immunotherapy
|
|
JP2022539248A
(ja)
|
2019-07-02 |
2022-09-07 |
フレッド ハッチンソン キャンサー リサーチ センター |
組換えａｄ３５ベクター及び関連遺伝子治療改善
|
|
AU2020315213A1
(en)
*
|
2019-07-17 |
2022-02-03 |
National University Of Singapore |
Functional binders synthesized and secreted by immune cells
|
|
CN114641308A
(zh)
|
2019-08-28 |
2022-06-17 |
伦敦国王学院 |
B细胞靶向的平行CAR(pCAR)治疗剂
|
|
US12552874B2
(en)
|
2019-11-26 |
2026-02-17 |
Ramot At Tel-Aviv University Ltd. |
Antibodies to carbohydrate antigens
|
|
CA3164666A1
(en)
*
|
2020-01-13 |
2021-07-22 |
Kanya Lakshmi RAJANGAM |
Bcma-directed cellular immunotherapy compositions and methods
|
|
AU2021357520A1
(en)
|
2020-03-05 |
2022-09-29 |
Neotx Therapeutics Ltd. |
Methods and compositions for treating cancer with immune cells
|
|
CN113402612A
(zh)
*
|
2020-03-17 |
2021-09-17 |
西比曼生物科技（香港）有限公司 |
靶向cd19和cd20的联合嵌合抗原受体及其应用
|
|
GB202005216D0
(en)
|
2020-04-08 |
2020-05-20 |
Autolus Ltd |
Cell
|
|
JP2023525049A
(ja)
*
|
2020-05-08 |
2023-06-14 |
シアトル・チルドレンズ・ホスピタル・ドゥーイング／ビジネス／アズ・シアトル・チルドレンズ・リサーチ・インスティテュート |
ナチュラルキラー細胞を標的とするキメラ抗原受容体（ｃａｒ）
|
|
WO2022031597A1
(en)
|
2020-08-03 |
2022-02-10 |
Kyverna Therapeutics, Inc. |
Methods of producing t regulatory cells, methods of transducing t cells, and uses of the same
|
|
US20230366893A1
(en)
*
|
2020-09-29 |
2023-11-16 |
Washington University |
Methods to determine risk of neurotoxicity
|
|
JP2024500847A
(ja)
|
2020-12-18 |
2024-01-10 |
センチュリー セラピューティクス，インコーポレイテッド |
適合可能な受容体特異性を有するキメラ抗原受容体システム
|
|
WO2022147444A2
(en)
|
2020-12-30 |
2022-07-07 |
Alaunos Therapeutics, Inc. |
Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof
|
|
WO2022165419A1
(en)
|
2021-02-01 |
2022-08-04 |
Kyverna Therapeutics, Inc. |
Methods for increasing t-cell function
|
|
CN117545771A
(zh)
*
|
2021-04-08 |
2024-02-09 |
克莱格医学有限公司 |
细胞免疫治疗的应用
|
|
CN117088975B
(zh)
*
|
2022-05-11 |
2024-06-25 |
东莞市朋志生物科技有限公司 |
抗白蛋白抗体、检测白蛋白的试剂和试剂盒
|
|
EP4522204A1
(en)
|
2022-05-11 |
2025-03-19 |
Autolus Limited |
Cd19/22 car t-cell treatment of high risk or relapsed pediatric acute lymphoblastic leukemia
|
|
CN116253794B
(zh)
*
|
2022-08-19 |
2025-04-04 |
首都医科大学宣武医院 |
一种用于car-t细胞调控的抗体及其应用
|
|
AU2024244733B2
(en)
|
2023-03-31 |
2025-12-11 |
AbelZeta Inc. |
Bispecific chimeric antigen receptors targeting cd20 and bcma
|
|
EP4719463A1
(en)
|
2023-05-30 |
2026-04-08 |
Autolus Limited |
Cd19car t-cell treatment of relapsed/refractory b-cell acute lymphoblastic leukaemia
|
|
EP4740011A1
(en)
|
2023-07-05 |
2026-05-13 |
Autolus Limited |
Method
|
|
CN119350497A
(zh)
*
|
2023-07-24 |
2025-01-24 |
星尘生物科技(上海)有限公司 |
人源化抗cd19单链可变区片段及其用途
|
|
GB202316184D0
(en)
|
2023-10-23 |
2023-12-06 |
Autolus Ltd |
Method
|
|
AU2024365682A1
(en)
|
2023-10-23 |
2026-04-30 |
Autolus Limited |
Products and methods for treating autoimmune diseases
|
|
EP4574838A1
(en)
|
2023-12-21 |
2025-06-25 |
Vilnius University |
Chimeric antigen receptor (car) with enhanced recruitment of signaling partners
|
|
GB202403564D0
(en)
|
2024-03-12 |
2024-04-24 |
Autolus Ltd |
Method
|
|
WO2025215360A1
(en)
|
2024-04-09 |
2025-10-16 |
Autolus Limited |
Method
|